Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3934874 | European Urology Supplements | 2007 | 7 Pages |
Abstract
The current level of evidence indicates that gemcitabine possesses clinical activity, but further confirmation is awaited from additional exploratory phase 2 and, preferably, phase 3 trials.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Paolo Gontero, Alessandro Tizzani,